{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:02:39Z","timestamp":1793325759955,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>The management of macrolide-resistant Mycobacterium avium complex (MR-MAC) pulmonary disease is difficult and is thought to be analogous to that of multidrug-resistant tuberculosis (MDR-TB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to clarify the cause of MR-MAC, to see how its management affected outcome, and to compare its prognosis with that of MDR-TB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The medical records of 102 consecutive cases with MR-MAC pulmonary disease at three tertiary hospitals for mycobacteriosis in metropolitan Tokyo and one in Aichi prefecture from 2005 to 2014 were reviewed. The data of 311 consecutive cases with MDR-TB were extracted from the medical data at Fukujuji Hospital.<\/jats:p>\n                    <jats:p>Measurements and Main Results: Of the 90 patients who met the criteria, 53 (58.9%) received inappropriate first-line treatment, and 28 (31.1%) deviated from the standard treatment because of the adverse effects of ethambutol. The survival rates for MR-MAC disease and MDR-TB were not significantly different (P\u2009=\u20090.6). Multivariate analysis showed that the combination of aminoglycoside and surgery resulted in the best treatment outcome (P\u2009=\u20090.02), although neither of the two factors reached significance by themselves. The continuation of clarithromycin and the addition of fluoroquinolones did not improve the outcome for the treatment of disease caused by MR-MAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Inappropriate prescription patterns and deviations from the standard treatment because of adverse drug reactions appeared to be the main causes of macrolide resistance in this patient series. Drug sensitivity testing should be performed at diagnosis to identify macrolide resistance and patients who may benefit from other therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201604-246oc","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T16:10:31Z","timestamp":1470931831000},"page":"1904-1911","source":"Crossref","is-referenced-by-count":156,"title":["Macrolide-Resistant\n                    <i>Mycobacterium avium<\/i>\n                    Complex Lung Disease: Analysis of 102 Consecutive Cases"],"prefix":"10.1093","volume":"13","author":[{"given":"Kozo","family":"Morimoto","sequence":"first","affiliation":[{"name":"Respiratory Disease Center, Fukujuji Hospital, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6181-4284","authenticated-orcid":false,"given":"Ho","family":"Namkoong","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, School of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, School of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, National Hospital Organization, Higashinagoya National Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Morino","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Division of Infectious Diseases, National Center for Global Health and Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"Respiratory Disease Center, Fukujuji Hospital, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, National Hospital Organization, Higashinagoya National Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohiko","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Clinical Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan"},{"name":"Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Takasaki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Division of Infectious Diseases, National Center for Global Health and Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoshiyama","sequence":"additional","affiliation":[{"name":"Respiratory Disease Center, Fukujuji Hospital, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Department of Mycobacteriology, National Institute of Infectious Diseases, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Respiratory Disease Center, Fukujuji Hospital, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, National Hospital Organization, Higashinagoya National Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Respiratory Disease Center, Fukujuji Hospital, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ishii","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, School of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuyuki","family":"Kurashima","sequence":"additional","affiliation":[{"name":"Respiratory Disease Center, Fukujuji Hospital, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Keio University Health Center, Keio University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Betsuyaku","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, School of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Goto","sequence":"additional","affiliation":[{"name":"Respiratory Disease Center, Fukujuji Hospital, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"key":"2026020502580300900_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502580300900_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccm.2014.10.005","article-title":"Treatment of slowly growing mycobacteria","volume":"36","author":"Philley","year":"2015","journal-title":"Clin Chest Med"},{"key":"2026020502580300900_bib3","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1164\/ajrccm.153.6.8665032","article-title":"Clarithromycin regimens for pulmonary Mycobacterium avium complex: the first 50 patients","volume":"153","author":"Wallace","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502580300900_bib4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1164\/rccm.200603-450OC","article-title":"Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease","volume":"174","author":"Griffith","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502580300900_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1513\/AnnalsATS.201304-085OC","article-title":"Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease","volume":"11","author":"Adjemian","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2026020502580300900_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1164\/ajrccm.149.5.8173775","article-title":"Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease","volume":"149","author":"Wallace","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502580300900_bib7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/clinids\/23.5.983","article-title":"Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus","volume":"23","author":"Griffith","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2026020502580300900_bib8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1086\/313644","article-title":"Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex","volume":"30","author":"Griffith","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2026020502580300900_bib9","first-page":"A5256","article-title":"Macrolide resistant Mycobacterium avium complex pulmonary disease - clinical analysis of 95 cases: an NTM-TRC (Tokyo Research Consortium) study [abstract]","volume":"191","author":"Morimoto","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502580300900_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/jac\/dkq536","article-title":"Evaluation of a rapid detection method of clarithromycin resistance genes in Mycobacterium avium complex isolates","volume":"66","author":"Inagaki","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2026020502580300900_bib11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2217\/fmb.14.60","article-title":"Drug susceptibility testing of nontuberculous mycobacteria","volume":"9","author":"van Ingen","year":"2014","journal-title":"Future Microbiol"},{"key":"2026020502580300900_bib12","volume-title":"Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes,","author":"CLSI","year":"2011","edition":"2nd ed"},{"key":"2026020502580300900_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/trstmh\/tru080","article-title":"Long term outcome of multidrug-resistant TB patients in Fukujuji Hospital in Japan","volume":"108","author":"Yoshiyama","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2026020502580300900_bib14","doi-asserted-by":"crossref","first-page":"e77385","DOI":"10.1371\/journal.pone.0077385","article-title":"Proposed definitions for epidemiologic and clinical studies of Mycobacterium avium complex pulmonary disease","volume":"8","author":"Plotinsky","year":"2013","journal-title":"PLoS One"},{"key":"2026020502580300900_bib15","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3201\/eid1911.130737","article-title":"Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010","volume":"19","author":"Marras","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2026020502580300900_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1513\/AnnalsATS.201303-067OC","article-title":"A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan","volume":"11","author":"Morimoto","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2026020502580300900_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review","volume":"36","author":"Prevots","year":"2015","journal-title":"Clin Chest Med"},{"key":"2026020502580300900_bib18","first-page":"487","article-title":"[A study of adverse drug reactions in the treatment of pulmonary Mycobacterium avium complex disease [in Japanese]","volume":"87","author":"Ichiki","year":"2012","journal-title":"Kekkaku"},{"key":"2026020502580300900_bib19","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/infdis\/174.6.1218","article-title":"Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model","volume":"174","author":"Bermudez","year":"1996","journal-title":"J Infect Dis"},{"key":"2026020502580300900_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1086\/513753","article-title":"Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida","volume":"25","author":"May","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2026020502580300900_bib21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1378\/chest.13-2538","article-title":"Macrolide\/Azalide therapy for nodular\/bronchiectatic mycobacterium avium complex lung disease","volume":"146","author":"Wallace","year":"2014","journal-title":"Chest"},{"key":"2026020502580300900_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.201408-1545OC","article-title":"Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease","volume":"191","author":"Jeong","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502580300900_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1513\/AnnalsATS.201308-266OC","article-title":"Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study","volume":"11","author":"Miwa","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2026020502580300900_bib24","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1128\/AAC.44.10.2619-2622.2000","article-title":"Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice","volume":"44","author":"Bermudez","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2026020502580300900_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.rmed.2013.09.014","article-title":"Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials","volume":"108","author":"Aksamit","year":"2014","journal-title":"Respir Med"},{"key":"2026020502580300900_bib26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijantimicag.2010.12.014","article-title":"Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium","volume":"37","author":"Sano","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"2026020502580300900_bib27","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1128\/AAC.02281-12","article-title":"Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen","volume":"57","author":"Koh","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2026020502580300900_bib28","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.5588\/ijtld.11.0068","article-title":"Experience with rifabutin replacing rifampin in the treatment of tuberculosis","volume":"15","author":"Horne","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026020502580300900_bib29","first-page":"625","article-title":"[Clinical experience using rifabutin for treating infection with Mycobacterium tuberculosis in elderly Japanese patients [in Japanese]","volume":"88","author":"Morimoto","year":"2013","journal-title":"Kekkaku"},{"key":"2026020502580300900_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11748-014-0402-1","article-title":"Surgical treatment of nontuberculous mycobacterial lung disease","volume":"62","author":"Shiraishi","year":"2014","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2026020502580300900_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccm.2014.11.004","article-title":"Surgical approach to pulmonary nontuberculous mycobacterial infections","volume":"36","author":"Mitchell","year":"2015","journal-title":"Clin Chest Med"},{"key":"2026020502580300900_bib32","volume-title":"Global tuberculosis report 2014. A report from the WHO.","author":"World Health Organization","year":"2014"},{"key":"2026020502580300900_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/tuld.1999.0227","article-title":"Molecular basis of clarithromycin-resistance in Mycobacterium avium intracellulare complex","volume":"80","author":"Jamal","year":"2000","journal-title":"Tuber Lung Dis"},{"key":"2026020502580300900_bib34","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/JCM.00555-13","article-title":"Rapid molecular detection of macrolide resistance in the Mycobacterium avium complex: are we there yet?","volume":"51","author":"Christianson","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2026020502580300900_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1164\/rccm.201411-2078ED","article-title":"Therapy for Mycobacterium avium complex lung disease. It ain\u2019t perfect, but it\u2019s progress","volume":"191","author":"Bag","year":"2015","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/11\/1904\/66768737\/annalsats_13_11_1904.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/11\/1904\/66768737\/annalsats_13_11_1904.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:58:12Z","timestamp":1770278292000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/13\/11\/1904\/8449536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,1]]},"published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201604-246oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,11]]},"published":{"date-parts":[[2016,11,1]]}}}